Advertisement
Screener

Talis Biomedical Corporation Earnings Per Share (Basic)

Talis Biomedical Corporation Earnings Per Share (Basic)

Talis Biomedical Corporation reported Earnings Per Share (Basic) of -$4.86 per share for the 3-month period ending 2024-06-30, per its 10-Q filed 2024-08-19.

Discontinued › Income Statement › Earnings Per Share

us-gaap:EarningsPerShareBasic · last filed 2024-08-19

  • Talis Biomedical Corporation earnings per share, basic for the quarter ending 2024-06-30 was -$4.86.
  • Talis Biomedical Corporation earnings per share, basic for the quarter ending 2024-03-31 was -$7.15.
  • Talis Biomedical Corporation earnings per share, basic for the quarter ending 2023-12-31 was -$7.39.
  • Talis Biomedical Corporation earnings per share, basic for the quarter ending 2023-09-30 was -$8.62.
  • Talis Biomedical Corporation earnings per share, basic for fiscal 2023 was -$34.12.
  • Talis Biomedical Corporation earnings per share, basic for fiscal 2022 was -$62.77.
  • Talis Biomedical Corporation earnings per share, basic for fiscal 2021 was -$8.48.
Period endEarnings Per Share, Basic 3 monthEarnings Per Share, Basic 3 month as first filedEarnings Per Share, Basic 6 monthEarnings Per Share, Basic 9 monthEarnings Per Share, Basic 9 month as first filedEarnings Per Share, Basic 12 monthEarnings Per Share, Basic 12 month as first filed
2024-06-30-$4.86
10-Q · filed 2024-08-19
-$12.01
10-Q · filed 2024-08-19
-$19.40
derived: net income ÷ weighted average shares · filed 2024-08-19
-$28.02
derived: net income ÷ weighted average shares · filed 2024-08-19
2024-03-31-$7.15
10-Q · filed 2024-05-08
-$14.54
derived: net income ÷ weighted average shares · filed 2024-08-19
-$23.16
derived: net income ÷ weighted average shares · filed 2024-08-19
-$31.44
derived: net income ÷ weighted average shares · filed 2024-08-19
2023-12-31-$7.39
derived: net income ÷ weighted average shares · filed 2024-03-28
-$16.01
derived: net income ÷ weighted average shares · filed 2024-03-28
-$24.28
derived: net income ÷ weighted average shares · filed 2024-08-19
-$34.12
10-K · filed 2024-03-28
2023-09-30-$8.62
10-Q · filed 2023-11-14
-$16.89
derived: net income ÷ weighted average shares · filed 2024-08-19
-$26.73
10-Q · filed 2023-11-14
-$41.58
derived: net income ÷ weighted average shares · filed 2024-08-19
2023-06-30-$8.27
10-Q · filed 2024-08-19
-$18.11
10-Q · filed 2024-08-19
-$32.97
derived: net income ÷ weighted average shares · filed 2024-08-19
-$47.39
derived: net income ÷ weighted average shares · filed 2024-08-19
2023-03-31-$9.84
10-Q · filed 2024-05-08
-$0.66
10-Q · filed 2023-05-11
-$24.70
derived: net income ÷ weighted average shares · filed 2024-08-19
-$39.14
derived: net income ÷ weighted average shares · filed 2024-08-19
-$54.14
derived: net income ÷ weighted average shares · filed 2024-08-19
2022-12-31-$14.87
derived: net income ÷ weighted average shares · filed 2024-03-28
-$29.31
derived: net income ÷ weighted average shares · filed 2024-03-28
-$44.32
derived: net income ÷ weighted average shares · filed 2024-03-28
-$62.77
10-K · filed 2024-03-28
-$4.24
10-K · filed 2023-03-22
2022-09-30-$14.44
10-Q · filed 2023-11-14
-$0.98
10-Q · filed 2022-11-03
-$29.45
derived: net income ÷ weighted average shares · filed 2023-11-14
-$47.91
10-Q · filed 2023-11-14
-$3.24
10-Q · filed 2022-11-03
-$7.35
derived: net income ÷ weighted average shares · filed 2023-11-14
2022-06-30-$15.01
10-Q · filed 2023-08-10
-$33.47
10-Q · filed 2023-08-10
-$4.39
derived: net income ÷ weighted average shares · filed 2023-11-14
-$5.89
derived: net income ÷ weighted average shares · filed 2023-11-14
2022-03-31-$1.25
10-Q · filed 2023-05-11
-$2.10
derived: net income ÷ weighted average shares · filed 2023-11-14
-$3.55
derived: net income ÷ weighted average shares · filed 2023-11-14
2021-12-31-$0.89
derived: net income ÷ weighted average shares · filed 2023-03-22
-$2.31
derived: net income ÷ weighted average shares · filed 2023-03-22
-$8.48
10-K · filed 2023-03-22
2021-09-30-$1.49
10-Q · filed 2022-11-03
-$8.41
10-Q · filed 2022-11-03